Logo do repositório
 
Publicação

Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

dc.contributor.authorTaylor , MJ
dc.contributor.authorBagust , A
dc.contributor.authorPereira, João
dc.contributor.authorMendes da Costa, S
dc.contributor.authorBeale, S
dc.contributor.authorShearer, A
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.pblElsevier
dc.date.accessioned2018-06-12T22:01:44Z
dc.date.available2018-06-12T22:01:44Z
dc.date.issued2006-01-01
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent73895
dc.identifier.issn1098-3015
dc.identifier.otherPURE: 406062
dc.identifier.otherPURE UUID: 032dbf83-70e5-4e26-8344-95096b2a5cc2
dc.identifier.otherresearchoutputwizard: 9534
dc.identifier.otherWOS: 000240922000149
dc.identifier.urihttps://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site
dc.identifier.urlhttps://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site
dc.language.isoeng
dc.peerreviewedyes
dc.subjectSDG 3 - Good Health and Well-being
dc.titleCost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effectsen
dc.typeconference object
degois.publication.firstPage
degois.publication.issue6
degois.publication.lastPage
degois.publication.titleValue In Health
degois.publication.volume9
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
COST_EFFECTIVENESS_OF_ROSIGLITAZONE.pdf
Tamanho:
72.16 KB
Formato:
Adobe Portable Document Format